(Q37668342)

21 August 2017

2 references

23 October 2022

Nanoparticle vaccines against respiratory viruses (English)

1 reference

respiratory tract infection

21 August 2017

0 references

1 reference

23 October 2022

Brian M Adair

1

1 reference

21 August 2017

1 July 2009

1 reference

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

21 August 2017

2 references

21 August 2017

23 October 2022

1

1 reference

21 August 2017

405-414

1 reference

21 August 2017

4

1 reference

Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development

21 August 2017

1 reference

Respiratory syncytial virus infection in adults

21 January 2018

1 reference

Bovine respiratory syncytial virus infection

21 January 2018

1 reference

Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies

21 January 2018

1 reference

Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology

21 January 2018

1 reference

Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium

21 January 2018

1 reference

Influenza virus assembly and budding at the viral budozone.

21 January 2018

1 reference

Replication and clearance of respiratory syncytial virus: apoptosis is an important pathway of virus clearance after experimental infection with bovine respiratory syncytial virus

21 January 2018

1 reference

The role of nasopharyngeal lymphoid tissue

21 January 2018

1 reference

Upper Respiratory Tract Immunity

21 January 2018

1 reference

Intranasal immunization with polymer-grafted microparticles activates the nasal-associated lymphoid tissue and draining lymph nodes.

21 January 2018

1 reference

Immunology of the tonsils.

21 January 2018

1 reference

Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses

21 January 2018

1 reference

Influence of maternal antibodies on neonatal immunization against respiratory viruses.

21 January 2018

1 reference

Targeting dendritic cells with biomaterials: developing the next generation of vaccines

21 January 2018

1 reference

The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen.

21 January 2018

1 reference

Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells.

21 January 2018

1 reference

Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.

21 January 2018

1 reference

Physical characterization and macrophage cell uptake of mannan-coated nanoparticles

21 January 2018

1 reference

In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles

21 January 2018

1 reference

Polysaccharide colloidal particles as delivery systems for macromolecules

21 January 2018

1 reference

Chitosan as a novel nasal delivery system for vaccines

21 January 2018

1 reference

Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.

21 January 2018

1 reference

Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity.

21 January 2018

1 reference

Influenza virus ISCOMs: antibody response in animals

21 January 2018

1 reference

Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines

21 January 2018

1 reference

The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses

21 January 2018

1 reference

Bovine respiratory syncytial virus ISCOMs--protection in the presence of maternal antibodies.

21 January 2018

1 reference

Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages

21 January 2018

1 reference

Pathogen recognition and development of particulate vaccines: does size matter?

21 January 2018

1 reference

Mechanisms of antigen uptake for presentation

21 January 2018

1 reference

Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres

21 January 2018

1 reference

Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.

21 January 2018

1 reference

Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity.

21 January 2018

1 reference

Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres.

21 January 2018

1 reference

Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus

21 January 2018

1 reference

Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection

21 January 2018

1 reference

Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines

21 January 2018

1 reference

Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia.

21 January 2018

1 reference

Polymeric nanoparticles as delivery system for influenza virus glycoproteins

21 January 2018

1 reference

Oral immunization with influenza virus in biodegradable microspheres

21 January 2018

1 reference

A severe outbreak of respiratory tract disease associated with bovine respiratory syncytial virus probably enhanced by vaccination with modified live vaccine

21 January 2018

1 reference

A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology

21 January 2018

1 reference

High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian white blue calves previously vaccinated with an inactivated BRSV vaccine

21 January 2018

1 reference

Epidemiological study of bovine respiratory syncytial virus infections in calves: influence of maternal antibodies on the outcome of disease

21 January 2018

1 reference

Complete protection of mice from respiratory syncytial virus infection following mucosal delivery of synthetic peptide vaccines

21 January 2018

1 reference

Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene

21 January 2018

1 reference

Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA.

21 January 2018

1 reference

Respiratory syncytial virus-induced immunoprotection and immunopathology

21 January 2018

1 reference

Microencapsulated human parainfluenza virus induces a protective immune response

21 January 2018

1 reference

Immunogenicity of bovine parainfluenza type 3 virus proteins encapsulated in nanoparticle vaccines, following intranasal administration to mice

21 January 2018

1 reference

Antigen-specific IgA and IgG responses in calves inoculated intranasally with ovalbumin encapsulated in poly(-lactide-co-glycolide) microspheres

21 January 2018

1 reference

Induction of systemic and mucosal immune response in cattle by intranasal administration of pig serum albumin in alginate microparticles.

21 January 2018

1 reference

Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro

21 January 2018

1 reference

Defense mechanisms against influenza virus infection in the respiratory tract mucosa.

21 January 2018

1 reference

12 December 2020

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

12 December 2020

Biodegradable microspheres containing influenza A vaccine: immune response in mice

1 reference

12 December 2020

Functional aspects of iscoms

1 reference

12 December 2020

Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides

1 reference

12 December 2020

Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines

1 reference

12 December 2020

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

12 December 2020

Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene

1 reference

12 December 2020

N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model

1 reference

12 December 2020

Cytotoxic T lymphocytes specific for influenza virus.

1 reference

12 December 2020

Gut- and bronchus-associated lymphoid tissue

1 reference

12 December 2020

Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.

1 reference

12 December 2020

Identifiers

DOI

10.1002/WNAN.45

1 reference

21 August 2017

0 references

1 reference

PubMed ID

20049806